SER Stock Analysis: Buy, Sell, or Hold?
SER - Serina Therapeutics, Inc.
$2.62
0.12 (4.80%)
â˛
5d:
-0.38%
30d:
+22.43%
90d:
+46.37%
WAIT
LOW Confidence
Analysis Updated: Sep 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When SER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SER is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SER is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SER is currently trading at $2.62, which is considered fair relative to its 30-day fair value range of $2.20 to $2.77.
Technical Outlook: Technically, SER is in a strong uptrend. Immediate support is located at $2.38, while resistance sits at $2.87. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.50 (+262.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SER is in a strong uptrend. Immediate support is located at $2.38, while resistance sits at $2.87. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.50 (+262.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.20 -
$2.77
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.8%)
- BULLISH: Trading 262.6% below Wall St target ($9.50)
- WARNING: Composite score 41/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.20 -
$2.77
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.38
Resistance Level
$2.87
Current Trend
Strong Uptrend
Technical data as of
Sep 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.50
Wall Street Target
$9.50
(+262.6%)
Revenue Growth (YoY)
154.9%
Earnings Growth (YoY)
-43.5%
Share & Embed Analysis
Last updated: September 03, 2026 12:29 AM ET
Data refreshes hourly during market hours. Next update: 1:29 AM
Data refreshes hourly during market hours. Next update: 1:29 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SER showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 44 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 44 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 53 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$563 | 40 SELL |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
